Zobrazeno 1 - 5
of 5
pro vyhledávání: '"D K, Frye"'
Autor:
T A, Buchholz, B S, Hill, S L, Tucker, D K, Frye, H M, Kuerer, A U, Buzdar, M D, McNeese, S E, Singletary, N T, Ueno, L, Pusztai, V, Valero, G N, Hortobagyi
Publikováno v:
Cancer journal (Sudbury, Mass.). 7(5)
The purpose of this study was to determine the clinical, pathological, and treatment factors that are predictive of local-regional recurrence and overall survival for patients with breast cancer that is refractory to neoadjuvant chemotherapy.This stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7de9659a354986b3f5485633fbfe09c1
https://pubmed.ncbi.nlm.nih.gov/11693900
https://pubmed.ncbi.nlm.nih.gov/11693900
Publikováno v:
Oncology nursing forum. 26(4)
To describe the new oral chemotherapeutic agent capecitabine (Xeloda, Roche Laboratories Inc., Nutley, NJ) and key concepts driving its development and to delineate the nursing impact of patient-administered, home-based chemotherapies.Published paper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ea86515204881701e164001ae1d70a2e
https://pubmed.ncbi.nlm.nih.gov/10337653
https://pubmed.ncbi.nlm.nih.gov/10337653
Publikováno v:
Cancer. 85(1)
The authors report results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with doxorubicin-containing combination chemotherapy at a single institution; this report is meant to serve as a reliable reference for sing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::73ae3bf1d15a56efba8d81422cde96a0
https://pubmed.ncbi.nlm.nih.gov/9921981
https://pubmed.ncbi.nlm.nih.gov/9921981
Autor:
A Y, Kinney, A, Sahin, S W, Vernon, R F, Frankowski, J F, Annegers, G N, Hortobagyi, A U, Buzdar, D K, Frye, K, Dhingra
Publikováno v:
Cancer. 80(12)
Sialyl-Tn (STn) represents an aberrantly glycosylated mucin epitope that is expressed in breast carcinoma and other adenocarcinomas and is an important factor in the development of novel immunotherapeutic approaches. The primary aim of the current st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::855de4fca54005824b3b64aaba753959
https://pubmed.ncbi.nlm.nih.gov/9404700
https://pubmed.ncbi.nlm.nih.gov/9404700
Publikováno v:
Surgical oncology clinics of North America. 4(4)
Seven hundred fifty-two patients with stage III disease (of those, 178 patients with inflammatory carcinoma) were treated with a combined modality approach at our institute in seven prospective studies. After three to four cycles of chemotherapy, eac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e51190bc105fa70c0a7dd557d7edbab2
https://pubmed.ncbi.nlm.nih.gov/8535907
https://pubmed.ncbi.nlm.nih.gov/8535907